AI Verdict
RNTX has stronger fundamentals based on our AI analysis.
ROIV vs RNTX Fundamental Comparison
| Metric | ROIV | RNTX |
|---|---|---|
| Revenue | $5.7M | $0.0 |
| Net Income | $-602.8M | $-49.9M |
| Net Margin | -10,501.1% | N/A |
| ROE | -14.1% | -294.8% |
| ROA | -11.5% | -206.4% |
| Current Ratio | 30.66x | 0.70x |
| Debt/Equity | 0.07x | 0.00x |
| EPS | $-0.88 | $-1.96 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ROIV vs RNTX: Frequently Asked Questions
Is ROIV or RNTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RNTX has stronger fundamentals. ROIV is rated STRONG SELL (92% confidence) while RNTX is rated STRONG SELL (95% confidence). This is not investment advice.
How does ROIV compare to RNTX fundamentally?
Roivant Sciences Ltd. has ROE of -14.1% vs Rein Therapeutics, Inc.'s -294.8%. Net margins are -10,501.1% vs N/A respectively.
Which stock pays higher dividends, ROIV or RNTX?
ROIV has a dividend yield of N/A or no dividend while RNTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ROIV or RNTX for long term?
For long-term investing, consider that ROIV has STRONG SELL rating with 92% confidence, while RNTX has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ROIV vs RNTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ROIV vs RNTX, the AI consensus favors RNTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.